Boston Scientific stock dipped Wednesday, but the medtech company beat Wall Street's fourth-quarter forecasts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback